Filter Results :

Your search for Drug Pipeline Analysis returned 35 reports

Sort by

Renal Cell Carcinoma - Global Drugs Market Forecast and Pipeline Analysis to 2021

16 May 2016  |  Published by:  iGATE Research
Renal cell carcinoma is the most common type of kidney cancer in adults. It accounts for approximately 3% of adult malignancies and 90-95% of neoplasms arising from the kidney. The global renal cell carcinoma drugs market is anticipated to cross US$ 4.3 Billion mark by 2021. There are many fac...

$ 1,190.00

Read More

Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis

30 Nov 2015  |  Published by:  La Merie Business Intelligence
This report describes and analyzes the situation of antibody-drug conjugates as of November 2015 regarding- ADC pipeline,- ADC technologies,- ADC stakeholders and- ADC business opportunities and commercial perspectives.Although the initial enthusiasm about antibody-drug conjugates has made room for ...

$ 2,511.30

Read More

Buccal Drug Delivery Systems: Opportunities And Challenges In Buccal, Sublingual Films, Tablets & Sprays - Detailed Analysis On Technologies And Pipeline Developmentpipeline Development

01 Oct 2015  |  Published by:  MP Advisors
Within the oral mucosal cavity, the buccal region offers an attractive route of administration for systemic drug delivery. The mucosa has a rich blood supply and it is relatively permeable.  The buccal mucosa offers several advantages for controlled drug delivery for extended periods of time. T...

$ 3,000.00
$ 2,550.00
( Save 15% )

Read More

US Blood Cancer Drug Market & Pipeline Analysis 2015

22 Jul 2015  |  Published by:  KuicK Research
Pharmaceutical companies have identified the opportunities to generate significant revenues from blood cancer segment in US. Escalating blood cancer incidences, high unmet medical necessities and demand for better therapeutics are some major factors behind growth of US blood cancer market segm...

$ 3,000.00

Read More

Global Alzheimer's Disease Drugs Market & Pipeline Drugs Market Analysis to 2020

13 Jul 2015  |  Published by:  iGATE Research
Alzheimer’s disease is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during t...

$ 1,100.00

Read More

Global Depression Therapy & Treatment Market – Depression drugs and devices, SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Electroconvulsive Pipeline Analysis, Global Analysis, Share, Growth, Trends, Forecast 2014 – 2020

17 May 2015  |  Published by:  Occams Business Research and Consulting
Depression is a state of emotion that affects thoughts, actions and often, sleeping patterns of affected individual. Depression affects behavior in terms of loss of appetite, being in a constant state of despair, feeling disconnected with friends/family and disinterest in activities that were ple...

$ 4,000.00

Read More

GLOBAL TRANSDERMAL DRUG DELIVERY MARKET TO 2020 - Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT Investigation

13 Feb 2015  |  Published by:  Kelly Scientific Publications
GLOBAL TRANSDERMAL DRUG DELIVERY MARKET TO 2017 Strategic Analysis, Technologies, Competitor Profiles, Financial Evaluation, Product Pipeline Assessment and SWOT InvestigationThis is a comprehensive account of the market size, segmentation, key players, SWOT analysis, influential technologies,...

$ 3,400.00

Read More

Worldwide - Hepatitis C Drugs Market and Pipeline Drugs Analysis to 2019

14 Oct 2014  |  Published by:  iGATE Research
Hepatitis C (hep C) is a viral disease caused by the Hepatitis C virus (HCV) and transmitted by blood, primarily in health care settings. It can progressively damage the liver, and, if left untreated, cause liver cirrhosis, liver cancer, and death. Hep C is the leading cause of liver cancer and l...

$ 900.00

Read More

Crohn's Disease Drug Market and Pipeline Analysis

21 May 2014  |  Published by:  PNS Pharma
Under the umbrella of inflammatory bowel diseases, Crohn’s disease and ulcerative colitis are two most common disorders. Though both these disorders have similar symptoms, the difference arises in the areas affected in the gastrointestinal tract (GI tract). The Crohn’s disease in most cases af...

$ 1,800.00

Read More

COPD Drug Market Opportunity & Clinical Pipeline Analysis

17 Apr 2014  |  Published by:  KuicK Research
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COP...

$ 2,200.00

Read More

Antibacterial Drugs Market (By Class - Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides and Phenicols, and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

21 Mar 2014  |  Published by:  Transparency Market Research
This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs is segmented on the basis of major classes of drugs, namely, aminoglycosides, B-lactams, tetracyclines, sulfonamides, quinolones/fluoroquinolones...

$ 4,795.00

Read More

Antibody-Drug Conjugates 2014 - a Business, Technology & Pipeline Analysis

19 Jan 2014  |  Published by:  La Merie Business Intelligence
Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis The report entitled, Antibody-Drug Conjugates 2014 – A Business, Technology & Pipeline Analysis“ published in January 2014 is based on the evaluation of more than 90 companies. The report analyzes established a...

$ 2,297.58

Read More

Europe Orphan Drug Pipeline Analysis 2014

01 Jan 2014  |  Published by:  PNS Pharma
Rare diseases are classified as those that affect fewer than 200,000 in the United States and less than 5 in 10,000 in the EU. The term “orphan” was associated with these drugs in order to reflect the lack of interest by pharma companies. In the European Union, orphan drugs are known as orphan...

$ 2,400.00

Read More

Europe Alzheimer's Disease Drug Pipeline Analysis

01 Jan 2014  |  Published by:  PNS Pharma
The incidence of Alzheimer’s disease has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been observed that close to 50% of dependency of aged people in Europe is attributed for by Alzheimer’s disease. The rapid growth in the prevalence...

$ 1,500.00

Read More

Europe Parkinson's Disease Drug Pipeline Analysis

01 Jan 2014  |  Published by:  PNS Pharma
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the ...

$ 1,000.00

Read More
Total 35 records.